Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis

OBJECTIVE: Infusion reaction is a major adverse event in patients with rheumatoid arthritis (RA) treated with infliximab. The possible factors including Fcγ receptor (FcγR) polymorphism associated with the development of infusion reactions in patients with RA receiving infliximab were prospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuyama, Ayumi, Nagasawa, Hayato, Suzuki, Katsuya, Kameda, Hideto, Kondo, Harumi, Amano, Kouichi, Takeuchi, Tsutomu
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015102/
https://www.ncbi.nlm.nih.gov/pubmed/20980704
http://dx.doi.org/10.1136/ard.2010.136283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015102/
https://www.ncbi.nlm.nih.gov/pubmed/20980704
http://dx.doi.org/10.1136/ard.2010.136283

Ejemplares similares